Matthew E. Hartman

896 total citations
20 papers, 560 citations indexed

About

Matthew E. Hartman is a scholar working on Molecular Biology, Immunology and Surgery. According to data from OpenAlex, Matthew E. Hartman has authored 20 papers receiving a total of 560 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Immunology and 3 papers in Surgery. Recurrent topics in Matthew E. Hartman's work include Immune cells in cancer (4 papers), Pluripotent Stem Cells Research (2 papers) and Congenital heart defects research (2 papers). Matthew E. Hartman is often cited by papers focused on Immune cells in cancer (4 papers), Pluripotent Stem Cells Research (2 papers) and Congenital heart defects research (2 papers). Matthew E. Hartman collaborates with scholars based in United States, India and China. Matthew E. Hartman's co-authors include Gregory G. Freund, Michael A. Laflamme, Dao‐Fu Dai, Jason C. O’Connor, Jonathan P. Godbout, Scott R. Manson, James J. Pesavento, Jeffrey A. Woods, K. Todd Keylock and Keith W. Kelley and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and The Journal of Immunology.

In The Last Decade

Matthew E. Hartman

19 papers receiving 542 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew E. Hartman United States 12 220 107 91 90 62 20 560
Ya Qiu China 12 202 0.9× 114 1.1× 99 1.1× 67 0.7× 80 1.3× 23 566
Khadija Iken United States 7 262 1.2× 85 0.8× 77 0.8× 124 1.4× 50 0.8× 8 509
Kevin Kwan United States 11 282 1.3× 176 1.6× 75 0.8× 102 1.1× 43 0.7× 39 795
Laura Molteni Italy 13 466 2.1× 120 1.1× 71 0.8× 115 1.3× 142 2.3× 32 899
Endre Kókai Hungary 11 236 1.1× 115 1.1× 49 0.5× 53 0.6× 63 1.0× 26 611
Yanbing Zhu China 17 315 1.4× 120 1.1× 49 0.5× 125 1.4× 80 1.3× 42 841
Anandakumar Shunmugavel United States 15 181 0.8× 62 0.6× 76 0.8× 54 0.6× 152 2.5× 20 746
Yueshui Jiang China 7 162 0.7× 62 0.6× 23 0.3× 71 0.8× 47 0.8× 15 521
Minfei Wu China 12 345 1.6× 63 0.6× 49 0.5× 56 0.6× 44 0.7× 17 549

Countries citing papers authored by Matthew E. Hartman

Since Specialization
Citations

This map shows the geographic impact of Matthew E. Hartman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew E. Hartman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew E. Hartman more than expected).

Fields of papers citing papers by Matthew E. Hartman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew E. Hartman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew E. Hartman. The network helps show where Matthew E. Hartman may publish in the future.

Co-authorship network of co-authors of Matthew E. Hartman

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew E. Hartman. A scholar is included among the top collaborators of Matthew E. Hartman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew E. Hartman. Matthew E. Hartman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hartman, Matthew E., et al.. (2020). COVID-19 Respiratory Failure: Targeting Inflammation on VV-ECMO Support. ASAIO Journal. 66(6). 603–606. 33 indexed citations
2.
Hartman, Matthew E., et al.. (2018). Evaluation of anterior capsular contraction syndrome after cataract surgery with commonly used intraocular lenses. Clinical ophthalmology. Volume 12. 1399–1403. 10 indexed citations
3.
Hartman, Matthew E., et al.. (2017). Role of Academic Drug Discovery in the Quest for New CNS Therapeutics. ACS Chemical Neuroscience. 8(3). 429–431. 15 indexed citations
4.
Hartman, Matthew E., Dao‐Fu Dai, & Michael A. Laflamme. (2015). Human pluripotent stem cells: Prospects and challenges as a source of cardiomyocytes for in vitro modeling and cell-based cardiac repair. Advanced Drug Delivery Reviews. 96. 3–17. 107 indexed citations
5.
6.
Hartman, Matthew E., Ivan O. Medvedev, Farid Moussavi‐Harami, et al.. (2014). An Optimized and Simplified System of Mouse Embryonic Stem Cell Cardiac Differentiation for the Assessment of Differentiation Modifiers. PLoS ONE. 9(3). e93033–e93033. 11 indexed citations
7.
Wu, Ling, Wei‐Ming Chien, Matthew E. Hartman, et al.. (2011). Regulation of MMP10 expression by the transcription factor CHF1/Hey2 is mediated by multiple E boxes. Biochemical and Biophysical Research Communications. 415(4). 662–668. 4 indexed citations
8.
Hartman, Matthew E., et al.. (2008). Ca2+/Calmodulin-Dependent Kinase Kinase α Is Expressed by Monocytic Cells and Regulates the Activation Profile. PLoS ONE. 3(2). e1606–e1606. 14 indexed citations
9.
Johnson, Daniel, Jason C. O’Connor, Matthew E. Hartman, Richard I. Tapping, & Gregory G. Freund. (2007). Acute Hypoxia Activates the Neuroimmune System, Which Diabetes Exacerbates. Journal of Neuroscience. 27(5). 1161–1166. 34 indexed citations
10.
Hartman, Matthew E., et al.. (2007). Phagocytosis of Cholesteryl Ester Is Amplified in Diabetic Mouse Macrophages and Is Largely Mediated by CD36 and SR-A. PLoS ONE. 2(6). e511–e511. 17 indexed citations
11.
O’Connor, Jason C., Ansuman T. Satpathy, Matthew E. Hartman, et al.. (2005). IL-1β-Mediated Innate Immunity Is Amplified in the db/db Mouse Model of Type 2 Diabetes. The Journal of Immunology. 174(8). 4991–4997. 77 indexed citations
12.
Hartman, Matthew E., et al.. (2004). Insulin Receptor Substrate-2-dependent Interleukin-4 Signaling in Macrophages Is Impaired in Two Models of Type 2 Diabetes Mellitus. Journal of Biological Chemistry. 279(27). 28045–28050. 38 indexed citations
13.
Keylock, K. Todd, et al.. (2003). Macrophage hypo-responsiveness to interferon-γ in aged mice is associated with impaired signaling through Jak-STAT. Mechanisms of Ageing and Development. 125(2). 137–143. 65 indexed citations
14.
Cengel, Keith A., et al.. (2003). Effectiveness of the SurePath liquid‐based Pap test in automated screening and in detection of HSIL. Diagnostic Cytopathology. 29(5). 250–255. 11 indexed citations
15.
Godbout, Jonathan P., James J. Pesavento, Matthew E. Hartman, Scott R. Manson, & Gregory G. Freund. (2002). Methylglyoxal Enhances Cisplatin-induced Cytotoxicity by Activating Protein Kinase Cδ. Journal of Biological Chemistry. 277(4). 2554–2561. 64 indexed citations
16.
Watson, R. Scott, Matthew E. Hartman, & Derek C. Angus. (2002). ICU USE AT THE END-OF-LIFE IN US CHILDREN. Critical Care Medicine. 30(Supplement). A147–A147. 2 indexed citations
17.
Watson, R. Scott, Matthew E. Hartman, Gilles Clermont, & Derek C. Angus. (2002). EPIDEMIOLOGY OF MECHANICAL VENTILATION NONINFANT US CHILDREN. Critical Care Medicine. 30(Supplement). A131–A131. 1 indexed citations
18.
Hartman, Matthew E., et al.. (2001). FRAP-Dependent Serine Phosphorylation of IRS-1 Inhibits IRS-1 Tyrosine Phosphorylation. Biochemical and Biophysical Research Communications. 280(3). 776–781. 36 indexed citations
19.
Hartman, Matthew E.. (1981). Mechanism of chemotherapeutic drug action in mouse vaginal epithelium. Archives of Dermatology. 117(7). 399–403.
20.
Heymann, Walter, Ernest Bueding, & Matthew E. Hartman. (1952). Metabolism of Renal Cortex in Nephrotic Syndrome of Rats.. Experimental Biology and Medicine. 79(2). 292–295. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ya Qiu Breakdown of academic impact, for papers by Khadija Iken Breakdown of academic impact, for papers by Kevin Kwan Breakdown of academic impact, for papers by Laura Molteni Breakdown of academic impact, for papers by Endre Kókai Breakdown of academic impact, for papers by Yanbing Zhu Breakdown of academic impact, for papers by Anandakumar Shunmugavel Breakdown of academic impact, for papers by Yueshui Jiang Breakdown of academic impact, for papers by Minfei Wu
Rankless by CCL
2026